Results 181 to 190 of about 66,165 (233)

Association of P‐Wave Parameters With Left Atrial Hemodynamics in Atrial Cardiomyopathy

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
In the present study, the validity of seven established P‐wave parameters in relation to left atrial hemodynamics was investigated. Our study suggests that advanced IAB is the strongest indicator of altered left atrial hemodynamics and, thus, AtCM.
Melissa Kazantzi   +10 more
wiley   +1 more source

Severe Dilated Cardiomyopathy with PLACK Syndrome Caused by a Novel Truncating Variant in the CAST Gene. [PDF]

open access: yesGenes (Basel)
Alkorashy M   +8 more
europepmc   +1 more source

Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 1, Page 40-56, January 2026.
Abstract Red blood cells (RBCs) have traditionally been seen as simple carriers of gases and nutrients in the body. One important non‐canonical function of RBCs in the cardiovascular system is the regulation of nitric oxide (NO) metabolism. It has been shown that RBCs can scavenge NO, transport NO metabolites and produce NO in hypoxic conditions ...
Anthea LoBue   +7 more
wiley   +1 more source

The Role of Multimodality Cardiac Imaging in the Diagnosis and Management of Chronic Chagas Cardiomyopathy. [PDF]

open access: yesJACC Case Rep
de Souza ACDAH   +5 more
europepmc   +1 more source

Eplerenone improves kidney function and cardiac performance in obese male mice

open access: yesDiabetic Medicine, Volume 43, Issue 1, January 2026.
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah   +8 more
wiley   +1 more source

Intersecting Endocrine Pathways in Cardiomyopathy: The Role of Metabolic Burden in Structural Heart Disease. [PDF]

open access: yesBiomedicines
Țica O   +8 more
europepmc   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo   +3 more
wiley   +1 more source

Intragenic <i>TTN</i> Deletions in a Single Family with Dilated Cardiomyopathy. [PDF]

open access: yesAppl Clin Genet
Wayhelova M   +5 more
europepmc   +1 more source

Cellular Senescence, Inflammaging and Cardiovascular Disease

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Aging is the most important yet unmodifiable risk factor for cardiovascular disease (CVD). As a result, targeting cardiovascular aging has emerged as a promising strategy to promote long‐term cardiovascular health. This review summarizes current knowledge on the effects of aging within the cardiovascular system as well as systemic processes ...
Lukas Zanders   +3 more
wiley   +1 more source

Use of pimobendan in cats: a practical evidence-based review. [PDF]

open access: yesJ Feline Med Surg
Gordon SG   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy